Evidence map›Paper›PMID 25072663›Full record

ArticleNature communications2014

Myocardium-derived angiopoietin-1 is essential for coronary vein formation in the developing heart.

Yoh Arita, Yoshikazu Nakaoka, Taichi Matsunaga, Hiroyasu Kidoya, Kohei Yamamizu, Yuichiro Arima, Takahiro Kataoka-Hashimoto, Kuniyasu Ikeoka, Taku Yasui, Takeshi Masaki and 16 more

Open access · hybridAbstract read
In one paragraph

Article in Nature communications, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 75 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. The Formation of Coronary Vessels in Cardiac Development and Disease.Cold Spring Harbor perspectives in biology · 2020
    Review
  14. Article
  15. Article
  16. Article
  17. Coronary Vasculature in Cardiac Development and Regeneration.Journal of cardiovascular development and disease · 2018
    Review
  18. Arterial Venous Differentiation for Vascular Bioengineering.Annual review of biomedical engineering · 2018
    Review
  19. Review
  20. HSPB7 is indispensable for heart development by modulating actin filament assembly.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 7 institutions in 3 countries.

Yoh AritaDepartment of Cardiovascular Medicine, Osaka University Graduate School of Medicine, 2-2, Yamadaoka, Suita, Osaka 565-0871, Japan.
Yoshikazu Nakaoka1] Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, 2-2, Yamadaoka, Suita, Osaka 565-0871, Japan [2] Precursory Research for Embryonic Science and Technology (PRESTO), Japan Science Technology Agency, 4-1-8, Honcho, Kawaguchi, Saitama 332-0012, Japan.
Taichi MatsunagaLaboratory of Stem Cell Differentiation, Institute for Frontier Medical Sciences/Department of Cell Growth &Differentiation, Center for iPS Cell Research and Application (CiRA), Kyoto University, 53, Shogoin-Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan.
Hiroyasu KidoyaDepartment of Signal Transduction, Research Institute for Microbial Diseases, Osaka University, 3-1, Yamadaoka, Suita, Osaka 565-0871, Japan.
Kohei YamamizuLaboratory of Stem Cell Differentiation, Institute for Frontier Medical Sciences/Department of Cell Growth &Differentiation, Center for iPS Cell Research and Application (CiRA), Kyoto University, 53, Shogoin-Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan.
Yuichiro ArimaDepartment of Physiological Chemistry and Metabolism, Graduate School of Medicine, University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.
Takahiro Kataoka-HashimotoDepartment of Cardiovascular Medicine, Osaka University Graduate School of Medicine, 2-2, Yamadaoka, Suita, Osaka 565-0871, Japan.
Kuniyasu IkeokaDepartment of Cardiovascular Medicine, Osaka University Graduate School of Medicine, 2-2, Yamadaoka, Suita, Osaka 565-0871, Japan.
Taku YasuiDepartment of Cardiovascular Medicine, Osaka University Graduate School of Medicine, 2-2, Yamadaoka, Suita, Osaka 565-0871, Japan.
Takeshi MasakiDepartment of Cardiovascular Medicine, Osaka University Graduate School of Medicine, 2-2, Yamadaoka, Suita, Osaka 565-0871, Japan.
Kaori YamamotoDepartment of Cardiovascular Medicine, Osaka University Graduate School of Medicine, 2-2, Yamadaoka, Suita, Osaka 565-0871, Japan.
Kaori HiguchiDepartment of Cardiovascular Medicine, Osaka University Graduate School of Medicine, 2-2, Yamadaoka, Suita, Osaka 565-0871, Japan.
Jin-Sung ParkNational Research Laboratory of Vascular Biology and Stem Cells, Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), 373-1, Guseong-dong, Daejeon 305-701, Korea.
Manabu ShiraiDepartment of Bioscience, National Cerebral and Cardiovascular Center Research Institute, 5-7-1, Fujishirodai, Suita, Osaka 565-8565, Japan.
Koichi NishiyamaDepartment of Physiological Chemistry and Metabolism, Graduate School of Medicine, University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.
Hiroyuki YamagishiDepartment of Pediatrics, Keio University School of Medicine, 35, Shinano-machi, Shinjuku-ku, Tokyo 160-8582, Japan.
Kinya OtsuCardiovascular Division, King's College London, 25, Coldharbour Lane, London SE5 9NU, UK.
Hiroki KuriharaDepartment of Physiological Chemistry and Metabolism, Graduate School of Medicine, University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.
Takashi MinamiLaboratory for Vascular Biology, Research Center for Advanced Science and Technology, University of Tokyo, 4-6-4, Komaba, Meguro-ku 153-8904, Tokyo, Japan.
Keiko Yamauchi-TakiharaDepartment of Cardiovascular Medicine, Osaka University Graduate School of Medicine, 2-2, Yamadaoka, Suita, Osaka 565-0871, Japan.
Gou Y KohNational Research Laboratory of Vascular Biology and Stem Cells, Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), 373-1, Guseong-dong, Daejeon 305-701, Korea.
Naoki MochizukiDepartment of Cell Biology, JST-CREST, National Cerebral and Cardiovascular Center Research Institute, 5-7-1, Fujishirodai, Suita, Osaka 565-8565, Japan.
Nobuyuki TakakuraDepartment of Signal Transduction, Research Institute for Microbial Diseases, Osaka University, 3-1, Yamadaoka, Suita, Osaka 565-0871, Japan.
Yasushi SakataDepartment of Cardiovascular Medicine, Osaka University Graduate School of Medicine, 2-2, Yamadaoka, Suita, Osaka 565-0871, Japan.
Jun K Yamashita1] Laboratory of Stem Cell Differentiation, Institute for Frontier Medical Sciences/Department of Cell Growth &Differentiation, Center for iPS Cell Research and Application (CiRA), Kyoto University, 53, Shogoin-Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan [2] Department of Stem Cell Differentiation, Institute for Frontier Medical Sciences, Kyoto University, 53, Shogoin-Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan.
Issei Komuro1] Department of Cardiovascular Medicine, Graduate School of Medicine, University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo 113-0033, Japan [2] Core Research for Evolutional Science and Technology (CREST), Japan Science Technology Agency, 4-1-8, Honcho, Kawaguchi, Saitama 332-0012, Japan.
Osaka University · JPThe University of Tokyo · JPKyoto University · JPKorea Advanced Institute of Science and Technology · KRNational Cerebral and Cardiovascular Center · JPKeio University · JPKing's College London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The origin and developmental mechanisms underlying coronary vessels are not fully elucidated. Here we show that myocardium-derived angiopoietin-1 (Ang1) is essential for coronary vein formation in the developing heart. Cardiomyocyte-specific Ang1 deletion results in defective formation of the subepicardial coronary veins, but had no significant effect on the formation of intramyocardial coronary arteries. The endothelial cells (ECs) of the sinus venosus (SV) are heterogeneous population, composed of APJ-positive and APJ-negative ECs. Among these, the APJ-negative ECs migrate from the SV into the atrial and ventricular myocardium in Ang1-dependent manner. In addition, Ang1 may positively regulate venous differentiation of the subepicardial APJ-negative ECs in the heart. Consistently, in vitro experiments show that Ang1 indeed promotes venous differentiation of the immature ECs. Collectively, our results indicate that myocardial Ang1 positively regulates coronary vein formation presumably by promoting the proliferation, migration and differentiation of immature ECs derived from the SV.

Indexed as

Angiopoietin-1AnimalsCell DifferentiationChimeraCoronary VesselsDNA PrimersEmbryonic Stem CellsGenetic VectorsGreen Fluorescent ProteinsHeartImmunohistochemistryIn Situ HybridizationMiceMyocardiumPolymerase Chain ReactionReal-Time Polymerase Chain ReactionAngiopoietin-1DNA Primersenhanced green fluorescent proteinGreen Fluorescent Proteins

Identifiers

PMID25072663
PMCPMC4124867
OpenAlexW1997848507

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.